-
Featured Press Release
During Ovarian Cancer Awareness Month, Aspira Women's Health highlights its innovative mission and leadership
Learn More -
Featured Presentation
Aspira Women's Health, Inc. to Host Key Opinion Leader call on Ovarian Cancer Diagnostics, Innovation Pipeline, and Rebranding Initiatives
Watch Here
Recent News
-
Aspira Women’s Health, Inc. Announces a Collaborative Agreement with Baylor Genetics for the Co-Development of an Ovarian Cancer Early-Detection test
Press Release
For a pdf of this press release please click here AUSTIN, Texas — November 19, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it has entered into a collaborative research agreement with Baylor Genetics (Houston, TX) to co-develop a novel Ovarian Cancer early-detection test. Ovarian cancer accounts for…
-
Aspira Women’s Health Reports Third Quarter 2020 Financial Results
Press Release
Conference Call scheduled for today, November 12th at 4:30 p.m. ET For a pdf of this press release please click here AUSTIN, Texas — November 12, 2020 — Aspira Women’s Health Inc. (“ASPIRA”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the third quarter ended September 30,…
-
Aspira Women’s Health, Inc. Strengthens Executive Leadership with New Appointments
Press Release
Team comprised of distinguished healthcare industry leaders in clinical development, translational medicine, strategy, and operational excellence, joins forces to accelerate innovation and market leadership position For a pdf of this press release please click here AUSTIN, Texas — November 10, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company today announces…
-
Aspira Women’s Health Strengthens Board of Directors with the Addition of Dr. Sandra E. Brooks
Press Release
AUSTIN, Texas — November 9, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of Sandra E. Brooks, MD, MBA to its Board of Directors. The addition of Dr. Brooks brings the Board composition to seven members with the majority now female. “It’s a tremendous honor to welcome Dr. Brooks…
-
Aspira Women’s Health, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
Press Release
AUSTIN, Texas — November 05, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it has been invited to present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum, taking place Thursday, November 19, 2020. Aspira Women’s Health is scheduled to present on Thursday, November 19th at 9:00amET.…